Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
September 19, 2024 07:00 ET | Lifecore Biomedical, Inc.
Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for...
arqq-logo.png
Arqit Quantum Inc. Announces 25:1 Reverse Share Split
September 19, 2024 07:00 ET | Arqit
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ) (“Arqit” or the “Company”), a leader in quantum safe encryption, today announces that, following approval by the...
22157.jpg
Asia-Pacific Continuous Bioprocessing Market Research 2024: Growing Demand for Continuous Bioprocessing due to the Flourishing Biopharmaceutical Sector - 10 Year Forecast to 2033
September 19, 2024 07:00 ET | Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Continuous Bioprocessing Market: Focus on Application, End User, Product, and Country - Analysis and Forecast, 2023-2033" report has been...
Asante_logo_4505.jpg
Asante Announces Approval of Base Shelf Prospectus for Ghanaian Bond Offering Up to US$400 Million
September 19, 2024 07:00 ET | Asante Gold Corporation
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Asante Gold Corporation (CSE: ASE | GSE: ASG |...
Stalilcla logo.png
Dr. Paulo Fontoura, MD, PhD, joins STALICLA as Chief Scientific and Clinical Development Advisor
September 19, 2024 07:00 ET | STALICLA
Press Release Dr. Paulo Fontoura, MD, PhD, joins STALICLA as Chief Scientific and Clinical Development Advisor Geneva, Switzerland – September 19, 2024 – STALICLA SA, a Swiss neuro precision...
MoneyHero_Logo.png
MoneyHero Group Reports Second Quarter 2024 Results
September 19, 2024 07:00 ET | MoneyHero Limited
MoneyHero Group Reports Second Quarter 2024 Results
ATHA_logo.png
ATHA Energy Expands Angilak Project by Acquiring Entire Prospective Corridor
September 19, 2024 07:00 ET | ATHA Energy Corp.
 HIGHLIGHTS: ATHA Energy has expanded its land package at the Angilak Project, acquiring the entire prospective Lac 50 structural corridor and an additional prospective parallel corridor. Both...
pyrologo.jpg
PyroGenesis Congratulates its Client EarthGrid on its Joint Venture with EnerTech to Deploy US$18B in Plasma-Powered Tunnel Boring Projects
September 19, 2024 07:00 ET | PyroGenesis Canada Inc.
MONTREAL, Sept. 19, 2024 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company that designs, develops,...
ACELYRIN, INC. Logo.jpg
ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024
September 19, 2024 07:00 ET | ACELYRIN, INC.
LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative...
gainlogo.png
Gain Therapeutics to Present Preclinical GT-02287 Data in Parkinson’s Disease Models Including Two Late-Breakers at Neuroscience 2024
September 19, 2024 07:00 ET | Gain Therapeutics, Inc.
BETHESDA, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of...